Thursday, December 30, 2010
Immunitor reports positive safety imm01 clinical trial against tuberculosis
Immune Network Ltd., advises that Immunitor has published data from the first half of the 120-patient imm01 clinical trial of its V5 immunomodulator product against tuberculosis, including difficult-to-treat forms of the disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment